Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All fluvoxamine studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchFluvoxamineFluvoxamine (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Repurposing Drugs for Covid-19 by a Developing Country

Valerio Pascua et al., Epidemiology International Journal, doi:10.23880/eij-16000234
May 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
27th treatment shown to reduce risk in November 2021
 
*, now known with p = 0.00011 from 20 studies, recognized in 3 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,900+ studies for 60+ treatments. c19early.org
Review of a multiphasic multidrug early treatment protocol for COVID-19 in Honduras, showing one death from 415 patients, which was for a patient not receiving early treatment (presenting on the 5th day in need of hospitalization and supplemental oxygen). Treatment included ivermectin, aspirin, colchicine, fluvoxamine, and famotidine.
Study covers ivermectin and fluvoxamine.
Valerio Pascua et al., 20 May 2022, Honduras, peer-reviewed, 31 authors, study period November 2020 - October 2021.
This PaperFluvoxamineAll
Repurposing Drugs for Covid-19 by a Developing Country
Valerio Pascua, Hernández Ci, Lewis As, Valenzuela Hd, Flores, Alvarenga Lf, Diaz, Chajtur Dg, Pineda E15, Vargas M 16, Caraccioli Gg, Garay, Lara R 15, Deras P 18, Leon V 15, Videa Eo, Stevens Ml, Eberhard D 20, Singh J 21, Sekhon Ak, Sierra Hoffman
Epidemiology International Journal, doi:10.23880/eij-16000234
Background: Early treatment of COVID-19 disease with repurposed drugs has been controversial. Most guidelines in the developed world recommend monoclonal antibodies or Ritonavir/Nirmatrelvir therapies for patients at risk of clinical deterioration, but accessibility to these in developing countries is a big challenge. The primary purpose of this study is to
References
Ackermann, Verleden, Kuehnel, Haverich, Welte, Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19, N Eng J Med
Ackermann, Verleden, Kuehnel, Haverich, Welte, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19, N Eng J Med
Awtry, Loscalzo, None, Aspirin. Circulation
Benefield, Skrip, Clement, Althouse, Chang, SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies, doi:10.1101/2020.09.28.20202028v1
Bryant, Lawrie, Dowswell, Fordham, Mitchells, Ivermectin for Prevention and Treatmentof COVID-19 Infection: A Systematic Review, Metanalysis, and Trial Sequential Anlaysis to Inform Clinical Guidelines, Am J Ther
Chaccour, Casellas, Matteo, Pineda, Montero, The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial, EClinicalMedicine
Choi, Bhat, Velasquez, Welch, Coronavirusin New
Farhi, How a blogger in Florida put on an early warning about the coronavirus crisis, The Washington Post
Hamed, Hagag, The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients, Medical Hypotheses
Horby, Landray, Haynes, Bailie, Juszczak, Dexamethasone in hospitalized patients with covid-19, N Eng J Med
Hotez, Batista, Amor, Ergonul, Figueroa, Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic, EClinicalMedicine
Huang, Wang, Li, Ren, Zhao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet
Kory, Meduri, Varon, Iglesias, Marik, Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of Covid-19, Am J Ther
Leung, Yao, Kraus, Colchicine-Update on mechanisms of action and therapeutic uses, Semin Arthritis Rheum
Liu, Blet, Smyth, Hongliang, The Science Underlying COVID-19 Implications for the Cardiovascular System, Circulation
Nasonov, Samsonov, The role of Interleukin 6 inhibitors in therapy of severe COVID-19, Biomed Pharmacother
Ontai, Zeng, Choi, Hoffman, Valerio Pascua et al., Early Multidrug Treatment of SARS-Cov-2 (COVID-19) and Decreased Case Fatality Rates in Honduras, Epidemol Int J
Pascua, Diaz, Medina, Contreras, Mistroff, A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients, PloS One
Pozo, Galindo, Nava, Jordán, A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients, Eur Rev Med Pharmacol Sci
Reyes, Hu, Teperman, Wampler Muskardin, Tardif, Anti-inflammatory therapy for COVID-19 infection: the case for colchicine, Ann Rheum Dis
Rodrigues, De Sá, Ishimoto, Becerra, Oliviera, Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients, J Exp Med
Sekhon, Repurposing Drugs for Covid-19 by a Developing Country, Epidemol Int J
Sukhatme, Reiersen, Vayttaden, Sukhatme, Fluvoxamine: A Review of Its Mechanism of Action and Its Rolein COVID-19, Front. Pharmacol
Vora, Lieberman, Wu, Inflammasome activation at the crux of severe COVID-19, Nature
Zaid, Puhm, Allaeys, Naya, Oudghiri, Platelets can associate with SARS-COV-2 RNA and are hyperactivated in COVID-19, Cir Res
Zhang, Chen, Zhu, Shu, Wang, Isolation of 2019-ncov from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (covid-19), China CDC Weekly
Zhang, Li, Niu, ACE2 and COVID-19 and the resulting ARDS, Postgrad Med J
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit